Moderna Price Target Raised To $234 From $208 At Piper Sandler
April 15, 2021 at 09:30 AM EDT
Piper Sandler analyst Edward Tenthoff raised the firm's price target on Moderna to $234 from $208 and reiterates an Overweight rating on the shares.